Alveolar mononuclear cells can develop into multinucleated osteoclasts:: An in vitro cell culture model

被引:0
|
作者
Sun, JS [1 ]
Chang, FHS
Hong, RC
Hung, TY
Lin, FH
Liu, HC
机构
[1] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Coll Med, Dept Orthoped Surg, Taipei 10764, Taiwan
[2] Natl Taiwan Univ, Coll Med, Inst Biomed Engn, Taipei, Taiwan
[3] Chung Yuan Christian Univ, Inst Biomed Engn, Tao Yuan, Taiwan
来源
关键词
alveolar mononuclear cells; osteoclasts; osteoblasts; in vitro;
D O I
10.1002/1097-4636(200010)52:1<142::AID-JBM18>3.3.CO;2-6
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Previous studies have shown that osteoclasts are derived from mononuclear cells of hemopoietic bone marrow and peripheral blood. The purpose of this study was to demonstrate the presence of multinucleated osteoclasts after adding alveolar mononuclear cells to new-born rat calvaria osteoblasts in vitro. To utilize osteoclast-free bone, fetal calvariae were obtained from newborn Wistar-rats and cultured in DMEM medium for 14 days. On the day of osteoblast culture, alveolar mononuclear cells were isolated from newborn Wistar rats with a serial washing method and then co-cultured with the calvarial osteoblasts. Bone resorption characteristics were observed both with light and scanning electron microscopy. When alveolar mononuclear cells were cultured for 14 days on the calvarial osteoblasts in response to 1 alpha, 25-dihydroxyvitamin D3, they formed tartrate-resistant acid phosphatase (TRAP)-positive mononuclear and multinucleated cells. Resorption pits were seen in the 7-14 days long-term cultures. These results indicate that osteoclasts can be derived from alveolar mononuclear cells in vitro when a suitable microenvironment is provided by calvarial osteoblasts and vitamin D-3. (C) 2000 John Wiley & Sons, Inc.
引用
收藏
页码:142 / 147
页数:6
相关论文
共 50 条
  • [31] An Optimised Human Cell Culture Model for Alveolar Epithelial Transport
    Ren, Hui
    Birch, Nigel P.
    Suresh, Vinod
    PLOS ONE, 2016, 11 (10):
  • [32] Ultrastructural study of cell-cell interaction between osteoclasts and osteoblasts/stroma cells in vitro
    Domon, T
    Yamazaki, Y
    Fukui, A
    Ohnishi, Y
    Takahashi, S
    Yamamoto, T
    Wakita, M
    ANNALS OF ANATOMY-ANATOMISCHER ANZEIGER, 2002, 184 (03) : 221 - 227
  • [33] Is it possible to obtain "True endothelial progenitor cells" by in vitro culture of bone marrow mononuclear cells?
    Zhang, Shi Ju
    Zhang, Hao
    Hou, Mai
    Zheng, Zhe
    Zhou, Jianye
    Su, Wenjun
    Wei, Yingjie
    Hu, Shengshou
    STEM CELLS AND DEVELOPMENT, 2007, 16 (04) : 683 - 690
  • [34] CD19+ pro-B cells can develop into dendritic cells in vitro
    Björck, P
    Kincade, PW
    JOURNAL OF LEUKOCYTE BIOLOGY, 1998, : 17 - 17
  • [35] A method to develop mock arteries suitable for cell seeding and in-vitro cell culture experiments
    Colombo, A.
    Zahedmanesh, H.
    Toner, D. M.
    Cahill, P. A.
    Lally, C.
    JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS, 2010, 3 (06) : 470 - 477
  • [36] CHARACTERISATION OF AN IN VITRO AGED CELL CULTURE MODEL
    Bunc, Marko
    Hanning, Sara M.
    Prieto, Jose M.
    Kristl, Julijana
    Orlu, Mine
    FARMACIA, 2019, 67 (02) : 240 - 247
  • [37] LUNG TRANSPLANTATION - PULMONARY CELL-LYSIS MEDIATED BY ALVEOLAR MONONUCLEAR-CELLS
    CUNNINGHAM, AC
    KIRBY, JA
    COLQUHOUN, IW
    DARK, JH
    TRANSPLANT INTERNATIONAL, 1992, 5 : S286 - S289
  • [38] Inhibitory influences of tranilast on multinucleated giant cell formation from monocytes by supernatant of concanavalin A-stimulated mononuclear cells
    Mizuno, K
    Okamoto, H
    Horio, T
    JOURNAL OF DERMATOLOGICAL SCIENCE, 2000, 24 (03) : 166 - 170
  • [39] Human mast cells decrease SLPI levels in type II – like alveolar cell model, in vitro
    Camilla Hollander
    Max Nyström
    Sabina Janciauskiene
    Ulla Westin
    Cancer Cell International, 3
  • [40] Human mast cells decrease SLPI levels in type II - like alveolar cell model, in vitro
    Hollander, Camilla
    Nystrom, Max
    Janciauskiene, Sabina
    Westin, Ulla
    CANCER CELL INTERNATIONAL, 2003, 3 (1)